HELPCybin D/B/A Helus Pharma

$6.24-31% 1Y

Price

-31%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

A flag to check, growing in the filings, the market undecided.

RyuScore 24 of 100: see how it is built
P/En/a
Market value$535.9M
1 year-31%
5 years-92%

Charts

As reported to the SEC, without any scoring.

For the full year FY2025, revenue was CAD 8.3M (+1239% year on year) and net income −CAD 113M.

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

4/19 checks · as of Oct 9, 2026

Conflicts between checks are named, never averaged, and thin data says so.